“Irisin Levels in Type 2 Diabetes Mellitus With and Without Non-Alcoholic Fatty Liver Disease: a Case-Control Study”. Prospects in Pharmaceutical Sciences, vol. 22, no. 3, Sept. 2024, pp. 210-8, https://doi.org/10.56782/pps.254.